These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 26593779)

  • 1. High mortality among children with sickle cell anemia and overt stroke who discontinue blood transfusion after transition to an adult program.
    McLaughlin JF; Ballas SK
    Transfusion; 2016 May; 56(5):1014-21. PubMed ID: 26593779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility and efficacy of chronic transfusion for stroke prevention in children with sickle cell disease.
    Mirre E; Brousse V; Berteloot L; Lambot-Juhan K; Verlhac S; Boulat C; Dumont MD; Lenoir G; de Montalembert M
    Eur J Haematol; 2010 Mar; 84(3):259-65. PubMed ID: 19912310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study of manual chronic partial exchange transfusion in children with sickle disease.
    Aloni MN; Lê PQ; Heijmans C; Huybrechts S; Devalck C; Azzi N; Ngalula-Mujinga M; Ferster A
    Hematology; 2015 Jun; 20(5):284-8. PubMed ID: 25133935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design of the DREPAGREFFE trial: A prospective controlled multicenter study evaluating the benefit of genoidentical hematopoietic stem cell transplantation over chronic transfusion in sickle cell anemia children detected to be at risk of stroke by transcranial Doppler (NCT 01340404).
    Chevret S; Verlhac S; Ducros-Miralles E; Dalle JH; de Latour RP; de Montalembert M; Benkerrou M; Pondarré C; Thuret I; Guitton C; Lesprit E; Etienne-Julan M; Elana G; Vannier JP; Lutz P; Neven B; Galambrun C; Paillard C; Runel C; Jubert C; Arnaud C; Kamdem A; Brousse V; Missud F; Petras M; Doumdo-Divialle L; Berger C; Fréard F; Taieb O; Drain E; Elmaleh M; Vasile M; Khelif Y; Bernaudin M; Chadebech P; Pirenne F; Socié G; Bernaudin F
    Contemp Clin Trials; 2017 Nov; 62():91-104. PubMed ID: 28821470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased complications of chronic erythrocytapheresis compared with manual exchange transfusions in children and adolescents with sickle cell disease.
    Woods D; Hayashi RJ; Binkley MM; Sparks GW; Hulbert ML
    Pediatr Blood Cancer; 2017 Nov; 64(11):. PubMed ID: 28544309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenectomy to Optimize Hemoglobin S Control in Children With Sickle Cell Anemia on Chronic Transfusion Therapy for Stroke Prevention.
    Black LV; Ramesar JS; Boston CH
    J Pediatr Hematol Oncol; 2019 Mar; 41(2):158-160. PubMed ID: 29668544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective RBC phenotype matching in a stroke-prevention trial in sickle cell anemia: a multicenter transfusion trial.
    Vichinsky EP; Luban NL; Wright E; Olivieri N; Driscoll C; Pegelow CH; Adams RJ;
    Transfusion; 2001 Sep; 41(9):1086-92. PubMed ID: 11552063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term results using hydroxyurea/phlebotomy for reducing secondary stroke risk in children with sickle cell anemia and iron overload.
    Greenway A; Ware RE; Thornburg CD
    Am J Hematol; 2011 Apr; 86(4):357-61. PubMed ID: 21442640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of red blood cell exchange, partial manual exchange, and simple transfusion concurrently with iron chelation therapy in reducing iron overload in chronically transfused sickle cell anemia patients.
    Fasano RM; Leong T; Kaushal M; Sagiv E; Luban NL; Meier ER
    Transfusion; 2016 Jul; 56(7):1707-15. PubMed ID: 26997031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beyond the transition of adolescents and young adults with sickle cell disease to adult care: Role of geography.
    Anderson N; Eckman JR; Ballas SK
    Am J Hematol; 2017 Jun; 92(6):E110-E112. PubMed ID: 28295532
    [No Abstract]   [Full Text] [Related]  

  • 11. A modified transfusion program for prevention of stroke in sickle cell disease.
    Cohen AR; Martin MB; Silber JH; Kim HC; Ohene-Frempong K; Schwartz E
    Blood; 1992 Apr; 79(7):1657-61. PubMed ID: 1558963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of automated erythrocytapheresis versus manual exchange transfusion to treat cerebral macrovasculopathy in sickle cell anemia.
    Koehl B; Sommet J; Holvoet L; Abdoul H; Boizeau P; Ithier G; Missud F; Couque N; Verlhac S; Voultoury P; Sellami F; Baruchel A; Benkerrou M
    Transfusion; 2016 May; 56(5):1121-8. PubMed ID: 27021622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic transfusion practice for children with sickle cell anaemia and stroke.
    Aygun B; McMurray MA; Schultz WH; Kwiatkowski JL; Hilliard L; Alvarez O; Heeney M; Kalinyak K; Lee MT; Miller S; Helms RW; Ware RE;
    Br J Haematol; 2009 May; 145(4):524-8. PubMed ID: 19344396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of total hemoglobin and hemoglobin S concentration on cerebral blood flow during transfusion therapy to prevent stroke in sickle cell disease.
    Hurlet-Jensen AM; Prohovnik I; Pavlakis SG; Piomelli S
    Stroke; 1994 Aug; 25(8):1688-92. PubMed ID: 8042222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfusion Therapy in Children With Sickle Cell Disease.
    Inati A; Mansour AG; Sabbouh T; Amhez G; Hachem A; Abbas HA
    J Pediatr Hematol Oncol; 2017 Mar; 39(2):126-132. PubMed ID: 27509379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transfusional iron overload in children with sickle cell anemia on chronic transfusion therapy for secondary stroke prevention.
    Kwiatkowski JL; Cohen AR; Garro J; Alvarez O; Nagasubramanian R; Sarnaik S; Thompson A; Woods GM; Schultz W; Mortier N; Lane P; Mueller B; Yovetich N; Ware RE;
    Am J Hematol; 2012 Feb; 87(2):221-3. PubMed ID: 22120913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimal Manual Exchange Transfusion Protocol for Sickle Cell Disease: A Retrospective Comparison of Two Comprehensive Care Centers in the United Kingdom and Canada.
    Mian HS; Ward R; Telfer P; Kaya B; Kuo KH
    Hemoglobin; 2015; 39(5):310-5. PubMed ID: 26114740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of chronic transfusion on incidence of pain and acute chest syndrome during the Stroke Prevention Trial (STOP) in sickle-cell anemia.
    Miller ST; Wright E; Abboud M; Berman B; Files B; Scher CD; Styles L; Adams RJ;
    J Pediatr; 2001 Dec; 139(6):785-9. PubMed ID: 11743502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydroxyurea (HU) for prevention of recurrent stroke in sickle cell anemia (SCA).
    Sumoza A; de Bisotti R; Sumoza D; Fairbanks V
    Am J Hematol; 2002 Nov; 71(3):161-5. PubMed ID: 12410569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encephaloduroarteriosynangiosis and encephalomyoarteriosynangiosis for treatment of moyamoya syndrome in pediatric patients with sickle cell disease.
    Griessenauer CJ; Lebensburger JD; Chua MH; Fisher WS; Hilliard L; Bemrich-Stolz CJ; Howard TH; Johnston JM
    J Neurosurg Pediatr; 2015 Jul; 16(1):64-73. PubMed ID: 25837886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.